Let7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer

Volume: 8, Issue: 1
Published: Aug 28, 2019
Abstract
Abnormal regulation and expression of microRNAs (miRNAs) has been documented in various diseases including cancer. The miRNA let ‐ 7 (MIRLET7) family controls developmental timing and differentiation. Let ‐ 7 loss contributes to carcinogenesis via an increase in its target oncogenes and stemness factors. Let ‐ 7 targets include genes regulating the cell cycle, cell signaling, and maintenance of differentiation. It is categorized as a tumor...
Paper Details
Title
Let7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
Published Date
Aug 28, 2019
Volume
8
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.